WEAV

WEAV

USD

Weave Communications Inc. Common Stock

$10.800-0.080 (-0.735%)

Echtzeitkurs

Healthcare
Health Information Services
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$10.880

Hoch

$10.990

Tief

$10.750

Volumen

0.07M

Unternehmensfundamentaldaten

Marktkapitalisierung

808.9M

Branche

Health Information Services

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.97M

Börse

NYQ

Währung

USD

52-Wochen-Spanne

Tief $8.16Aktuell $10.800Hoch $17.63

KI-Analysebericht

Zuletzt aktualisiert: 29. Apr. 2025
KI-generiertDatenquelle: Yahoo Finance, Bloomberg, SEC

WEAV: Weave Communications Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: WEAV Generate Date: 2025-04-29 11:13:47

Alright, let's break down what's been going on with Weave Communications (WEAV) based on the latest info. Think of this as chatting about the stock over coffee – keeping it simple and to the point.

The Latest Buzz (News Vibe)

So, what's the news telling us? It's a bit of a mixed bag, honestly.

On the positive side, Weave just announced a new hook-up with something called Veradigm. This integration is supposed to make things smoother for their healthcare customers, helping them manage communications better. That's good news for the business itself – potentially opening up new doors or making their service stickier for existing users.

But here's the flip side: a couple of Wall Street analysts, folks who get paid to follow these companies closely, recently lowered their price targets for Weave. Stifel dropped theirs from $20 to $16, and Piper Sandler went from $17 down to $14. Now, they both still say "Buy" or "Overweight" on the stock, which sounds positive, but cutting the target price like that usually means they see less potential growth or value than they did before. That's something investors definitely notice.

There was also news about when they'll release their first-quarter financial results – that's just a date announcement, pretty standard stuff, but it means actual numbers are coming soon, which is a big event for any stock.

Putting the news together, you've got a positive business development offset by analysts dialing back their expectations a bit.

Checking the Price Tag (Price Action)

Looking at the stock chart over the last few months tells a clear story, and it's been a bit rough. Back in late January and early February, the stock was trading up around the $16-$17 mark. Then, around late February, it took a pretty sharp dive. It bounced around in the $10-$12 range for a while through March.

More recently, in early April, it dipped down into the $9s. But lately, it seems to have found its footing and has started to climb back up a little, closing recently around $10.36. So, the big picture is a significant drop from earlier highs, but the very recent trend shows a bit of a bounce or stabilization.

What the AI Thinks Might Happen (Future Predictions)

We've got some AI predictions for the next few days. The model is calling for the price to tick up:

  • Today: Up about 2.58%
  • Tomorrow: Up about 2.25%
  • The Day After: Up about 3.63%

If these predictions play out, it suggests the recent slight upward movement could continue in the very near term. The AI model seems pretty confident in its forecast, too.

Putting It All Together: What's the Play?

Okay, let's try to make sense of this.

You've got a company making positive moves on the business side (the integration). The stock price took a hit but seems to be trying to recover lately. The AI is predicting more upward movement in the immediate future. On the other hand, analysts just lowered their price targets, and when you peek at the company's fundamentals (like its high P/E ratio, lower growth, and debt), they don't look super strong right now.

Based on the recent price bounce, the positive AI prediction, and some of the technical signals mentioned in the recommendation data (like buying pressure and a bullish MACD crossover), the apparent near-term leaning seems to be cautiously positive. It looks like there's some momentum building after the recent dip.

  • Potential Entry Consideration: If you were thinking about this stock and felt comfortable with the risks, the area right around the recent closing price (say, $10.30 to $10.40) could be a spot to consider, aligning with the current momentum and the AI's short-term outlook. The recommendation data also pointed to this range as potential entry points.
  • Potential Exit/Stop-Loss Consideration: To manage risk, setting a stop-loss below recent lows makes sense. The recommendation data suggests $9.32, which is below the early April dip and seems like a reasonable level where if the price falls below it, the recent bounce might be over. For taking profits, the recommendation data suggests $11.16. This is above the current price and could be a target if the upward trend continues, perhaps hitting some resistance from earlier trading ranges. The AI's projected upward trend also supports looking for a higher exit point.

A Quick Look at the Company

Just remember, Weave is focused on providing software for small and medium healthcare businesses – things like phone systems, texting, payments, and scheduling. The Veradigm integration fits right into that. It's a relatively small company (market cap around $775 million), which can sometimes mean bigger price swings. Also, that high P/E ratio (around 94x) is quite high compared to typical standards, suggesting investors are paying a lot for current earnings, which ties back to those fundamental concerns.

Important Disclaimer: This analysis is just based on the provided data and is for informational purposes only. It's not financial advice. Stock markets are risky, and prices can go down as well as up. You should always do your own thorough research or talk to a qualified financial advisor before making any investment decisions.

Ähnliche Nachrichten

BusinessWire

Weave Recognizes Critter Fixers with Healthcare Heroes Grant

Weave (NYSE:WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today recognized Dr. Vernard Hodges, DVM, and Dr. Terrence Ferguson, DVM,

Mehr anzeigen
Weave Recognizes Critter Fixers with Healthcare Heroes Grant
Analyst Upgrades

Raymond James Maintains Strong Buy on Weave Communications, Lowers Price Target to $17

Raymond James analyst Alexander Sklar maintains Weave Communications with a Strong Buy and lowers the price target from $20 to $17.

Mehr anzeigen
Raymond James Maintains Strong Buy on Weave Communications, Lowers Price Target to $17
BusinessWire

Weave Now Integrates with Veradigm

New integration unlocks Weave features to help streamline communication workflows Weave (NYSE:WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare

Mehr anzeigen
Weave Now Integrates with Veradigm
Analyst Upgrades

Stifel Maintains Buy on Weave Communications, Lowers Price Target to $16

Stifel analyst Parker Lane maintains Weave Communications with a Buy and lowers the price target from $20 to $16.

Mehr anzeigen
Stifel Maintains Buy on Weave Communications, Lowers Price Target to $16
BusinessWire

Weave Announces Date of First Quarter 2025 Financial Results and Conference Call

Weave (NYSE:WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the first quarter

Mehr anzeigen
Weave Announces Date of First Quarter 2025 Financial Results and Conference Call
Analyst Upgrades

Piper Sandler Maintains Overweight on Weave Communications, Lowers Price Target to $14

Piper Sandler analyst Brent Bracelin maintains Weave Communications with a Overweight and lowers the price target from $17 to $14.

KI-VorhersageBeta

KI-Empfehlung

Bullisch

Aktualisiert am: 3. Mai 2025, 19:18

BärischNeutralBullisch

63.5% Konfidenz

Risiko & Handel

Risikostufe3/5
Mittleres Risiko
Geeignet für
Aggressiv
Handelsleitfaden

Einstiegspunkt

$10.83

Gewinnmitnahme

$11.65

Stop-Loss

$9.72

Schlüsselfaktoren

DMI zeigt bärischen Trend (ADX:23.2, +DI:6.3, -DI:9.8), was zur Vorsicht mahnt
Aktueller Preis ist extrem nah am Unterstützungsniveau ($10.82), was auf eine starke Kaufgelegenheit hindeutet
Handelsvolumen ist 4.4x Durchschnitt (7,947), was auf extrem starken Kaufdruck hindeutet
MACD -0.0328 liegt unter der Signallinie -0.0273, was auf einen bärischen Crossover hindeutet

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.